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IMPORTANCE Ex vivo dermoscopy (EVD) with derm dotting (DD) improves clinicopathologic
correlation and the quality of diagnosis in skin tumors.
OBJECTIVE To compare the diagnostic performance of the standardmethod of skin biopsy
processing with the practice of EVDwith DD.
DESIGN, SETTING, AND PARTICIPANTS This retrospective study compares the diagnostic
performance in 6526 skin biopsy specimens examined from 2008 to 2010with a standard
method of processing with 8584 biopsy specimens examined in 2015 with EVD and DD. Data
were analyzed from January 1 to March 31, 2016. A total of 15 110 skin biopsy specimens were
included. The biopsy specimens from 2008 to 2010were processed in a hospital-based
general pathology laboratory; the biopsy specimens from 2015 were processed in a private
dermatopathology laboratory. Biopsy specimens from both periods were diagnosed by the
same dermatopathologist.
MAIN OUTCOMES ANDMEASURES The primary outcomemeasures were clinicopathological
characteristics, usefulness of EVDwith DD, and turnaround times (TATs).
RESULTS Use of EVDwith DD increased the detection of positive sectionmargins in
nonmelanoma skin cancer from 8.4% to 12.8%. Themost significant increase was seen in
Bowen disease, invasive squamous cell carcinoma, and a superficial type of basal cell
carcinoma (BCC). With EVD and DD, a specific clinicopathologic diagnosis was made in 27.7%
of nevi compared with only 10.3% using the standardmethod. The incidence of moderately
and severely dysplastic nevi increased from 1.0% to 7.2% and from0.6% to 1.4%,
respectively. The detection of ulceration in melanomas with thicker than 1 mm increased from
24.0% to 31.3%. The number of nevi-associatedmelanomas increased from 15.5% to 33.3%.
The number of collision lesions from 0.07% to 1.07%. The TAT for nevi decreased from 2 days
to 1 day, for melanomas from 5 days to 2 days, and for BCC from 2 days to 1 day.
CONCLUSIONS AND RELEVANCE Ex vivo dermoscopy and DDwith adapted sectioning in a
dermatopathology setting allows amore accurate and less time consuming histopathologic
diagnosis of skin tumors. These findings suggest that pathologists involved in skin tumor
evaluation should be encouraged to learn dermoscopy and replace random transverse cutting
with lesion-specific and DD-guided cutting.
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M ostpathology laboratoriesprocess skinbiopsy speci-mens without access to clinical and/or dermo-scopic images. Macroscopy of skin tumors is usu-
ally limited to a quick visual inspection, measurement of the
lesion, standard transverse sectioning, and randomcutting at
2 to 3 different levels.
Since the introduction of dermoscopy in the follow-up of
pigmented skin lesions, focal areas that are visible only with
dermoscopy may be the reason for diagnostic excision of le-
sions. Communication of this information to the pathologist
maybeof importance for a correct evaluationof these lesions.1
A routine diagnostic procedure submits only 2%or less of the
excised tissue for examination.2 This is a worrisome fact, es-
pecially formelanocytic tumors , asonecan imagine that small
specific areas of concern for the clinician canbemissedby the
pathologist if thesearenotdiscernablebythenakedeye.Merkel
et al3 appliedamicropunchduring invivodermoscopy tomark
these areas of interest, which can, however, create an artifact
and result in detaching of tissue.
In2007,Scopeetal4described theaddedvalue thatexvivo
dermoscopy (EVD) can give to the pathologist by guiding tis-
sue sectioning. Cabete et al5 found that the combined use of
EVD and histopathology improves clinicopathological corre-
lation andallows selectionof representative areas for section-
ing. In 13.1%of their cases, a different final diagnosiswas ren-
dered after dermoscopy-guided specimen sectioning. Since
2011wehave systematicallyusedEVDwithdermdotting (DD)
inourdermatopathology laboratory.With this simpleandeasy
method, focal areas or suspected section planes observed on
EVD are marked with nail varnish. This method of derm dot-
ting was described by our team in 2013.6 Others have after-
ward implemented this method in the examination of pig-
mented lesions.7 The dotting method was also successfully
used during oral surgery.8 In a systematic comparison of 101
tumoral skin lesions, we demonstrated that EVD is broadly
similar to in vivo dermoscopy but also has clear differences,
providingpossibledirection to target tissue forprocessing and
examination.9
In thepresent studyweevaluated the impact of EVDwith
DDon the reliability of pathologicalmargin evaluation andac-
curacy of diagnosis. We also looked at the impact on time of
thismethodbycomparingadditional cutsandturnaroundtime
(TAT) (time from tissue cutting to pathological protocol).
Methods
Skin Biopsy Specimens and Histological Processing
We compared 6526 skin biopsy specimens processed from
January 1, 2008, to December 31, 2010, in a general pathol-
ogy laboratorywith 8584 skin biopsy specimens examined in
a dermatopathology setting from January 1 to December 31,
2015. The skin biopsy specimens processed in this new der-
matopathology setting can be considered comparable with
those in the general hospital in termsof referred cases andpa-
tient population, since all the dermatologists sending to the
generalhospitalpathology laboratory switched to thenewder-
matopathology laboratory. The number of skin biopsy speci-
mens increased through growth of the existing dermatology
practices and by referral of cases from dermatologists at new
private dermatology practices in the same region.
Because the submittingdermatologypracticeswere all lo-
cated outside the hospital, samples from both periods were
considered comparable. The samedermatopathologist (M.H.)
diagnosed the lesions from both periods.
The lesion specimens from the first timeperiodwere pro-
cessed using the standard transverse method for skin biopsy
specimen processing. In first instance, skin tumors were in-
spectedbya technicianby thenakedeye.Measurementswere
taken, and a schematic drawing of lesion wasmade. The bot-
tomsidewas inked.The lesionwas standardbread-loaf cut ev-
ery 3 mm, with horizontal processing of tips. On 1 micro-
scopic slide, 3 different levels of microtome cuts were
assembled. Paraffin ribbons were conserved for possible ad-
ditional staining.
Ex vivodermoscopy andDDwereusedduring the second
timeperiod. In thedermatopathology laboratory setting, skin
tumorsare inspectedbyatechnicianbythenakedeyeandmea-
sured. The technicians are trained in dermoscopy and decide
if a dermoscopic image needs to be taken. A dermoscopic im-
age (EVD, takenwithaPowerShotG11,Canon;Dermlite3, 3Gen
Inc) was made of all flat melanocytic lesions, all lesions sus-
picious for dysplasia or skin cancer (bothmelanomaandnon-
melanoma), andwhen specific dermoscopic informationwas
provided by the clinician. Also, when a focal area of interest
or suspect margin was noticed, a dermoscopic picture was
made. When a technician was in doubt, the advice of the pa-
thologist was asked. The images were only connected to the
final histopathological diagnosis and no other personal data
from patients were included. Moreover, according to Belgian
law , nowritten informed consentwas required.We therefore
waived submission to the local human subjects ethics com-
mittee.
The followinghandlingprotocolwasused (eFigure 1 in the
Supplement): a horizontal border line was made on the skin
rim with black nail varnish to orient the specimen (Figure 1).
One half of the bottom side was inked green, the other half
black. Focal lesions seen on dermoscopy weremarkedwith a
nail varnish dot. Different colors could be used. The varnish
Key Points
Question What is the diagnostic performance of processing skin
tumors with ex vivo dermoscopy (EVD) and derm dotting (DD)
compared with the standardmethod?
Findings We observed that EVD and DD significantly increase the
detection of positive sectionmargins in nonmelanoma cancers
and result in a better recognition of specific clinicopathological
subtypes of nevi; a higher incidence of moderately and severely
dysplastic nevi, nevi-associatedmelanomas, and collision tumors;
and a decrease in themedian turnaround time for melanocytic
tumors.
Meaning Ex vivo dermoscopy and DD permit a more accurate and
less time-consuming histologic diagnosis of skin tumors.
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dotwasdiscernableunder themicroscopeasagranularbrown-
gray plaque on top of the horny layer (Figure 2). Punch bi-
opsy specimens, taken to invest inflammatory diseases,were
dotted in the center. Controlledmicrotome cutting was done
until the area of interest (dotted) was reached. In addition, 2
previous depths were mounted on the same slide. Orienta-
tion, inking, nail varnish, and section planes were indicated
on a drawing to help orient the tissue by the pathologist. Par-
affin ribbonswere conserved for possible additional staining.
Mostbenignmelanocytic lesionswerebread-loaftransverse-
sectionedwithoutprocessingof tips. Innonmelanomaskincan-
cer lesions, the tipswere processed. In atypicalmelanocytic le-
sions andmelanomas, the transverse sectionswere oriented to
include the different structures, suspect margins, or focal le-
sionsseenonEVD.Inelongatedlesionswithcleartransversemar-
gins on EVD, horizontal or tangential sections were made. Ac-
ral nevi were cut perpendicular to the parallel ridge pattern.
Outcome
To evaluate the quality of the diagnostic process, the follow-
ing featureswere systematically scoredandcompared forboth
periods: (1) the proportion of positive sectionmargins in non-
melanoma skin cancer lesions; (2) the proportion of nevi sub-
types; (3) the proportion ofmoderately and severely dysplas-
tic nevi, melanoma in situ, and invasive melanomas; (4) the
proportion of nevi-associated melanomas; (5) the incidence
ofulceration inmelanomas thicker than 1mm;and (6) thepro-
portion of collision lesions.
Toevaluate theeconomical andpractical consequencesof
this extra macroscopic work, the number of deeper cuts and
TATs from gross sectioning until the electronic validation of
the definitive protocol was compared for both periods.
All categorical variables were compared using Pearson χ2
test.MedianTATwas comparedusingMann-Whitney test. All
statistical testswere 2-tailed, and P < .05was considered sta-
tistically significant. Statistical analysis was done using SPSS
software (version 21.0; IBM).
Results
PositiveMargins in Nonmelanoma Skin Cancer
With EVD and DD, the number of nonmelanoma skin cancer
lesions with positive section margins increased significantly
from 8.4% to 12.8% (P < .001) (Table 1). In squamous cell car-
cinoma (SCC), the prevalence of positive margins increased
from 8.7% to 16.9% (P < .001). For Bowen disease and in situ
squamouscarcinoma (ISCC), thisnumber increased from9.3%
19.1% (P = .02) and from 8.6% to 15.7% (P < .001), respec-
tively. In thegroupofBCC,apositivemarginwas found in 11.1%
comparedwith 8.3%without EVDandDD (P = .02). In the su-
perficial type of BCC, the incidence of positive margins in-
creased from 1.8% to 4.8% (P = .046).
Melanocytic Lesions
Of6526biopsy specimens seen from2008 to 2010, 1946were
diagnosedasnevi (29.8%)comparedwith2808of8584(32.7%)
in 2015 (Table 2). For both periods, 2% of biopsy specimens
weremelanomas. For Miescher, flat, blue, and spitzoid types
ofnevi, a similar incidencewas found in the2periods (respec-
tively, 15.6%vs 14.6%, 14.2%vs 14.8%,2.5%vs2.0%,and3.8%
vs 3.2%). Only for Unna type nevi was a significant increase
found (from23% to 31.4%). In addition to these commonvari-
ants, with EVD and DD, 27.7% of nevi were diagnosed as nevi
with special clinicopathological characteristics comparedwith
only 10.3% before using EVD and DD (P < .001). Table 2 lists
the incidence of these subtypes for both methods. The num-
ber of nevi with moderate dysplasia increased from 1.0% to
7.2% (P < .001), whereas the number of nevi with severe dys-
plasia increased from 0.6% to 1.4% (P = .005).
Figure 1. Example of Collision of a Basal Cell Carcinoma in a Flat Nevus
Basal cell carcinoma in flat nevusA Original magnification × 12.5B
Top
Top
Bottom
Bottom
A, Dotting of the pale area in this pigmented lesion (circle) on the chest of a
woman in her 40s identified a superficial basal cell carcinoma in collision with a
flat nevus. The vertical line indicates the section plane. A horizontal border line
of black nail varnish was applied to orient the specimen (arrowhead).
B, Histopathologic image, hematoxylin-eosin. A and B, “Top” and “bottom”
indicate the top and bottom of the section plane.
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In the periods 2008 to 2010 and 2015, similar numbers of
melanomainsituwereobserved (respectively,0.6%and0.7%).
Also, the incidenceof invasivemelanomaswas similar forboth
periods (1.3% and 1.4%). Therewas an increase in the diagno-
sisof residualnevi inmelanomas from15.2%to33.3%(P= .06).
A trend toward an increase was found for ulceration inmela-
nomas thicker than 1 mm (from 24.0% to 31.3%; P = .54).
Collision Lesions
Exvivodermoscopy andDD revealed a collision lesion in 1.1%
of thecases, comparedwithonly0.07%of casesdiagnosedbe-
tween 2008 and 2010 (P < .001).
Deeper Cuts
Comparing both periods, a slight, nonsignificant, increase in
demand for deeper cuts was found using EVD and DD (6.4%
vs 5.3% using the standard method). For nonmelanoma skin
cancer, a decrease was found (from 3.8% to 2.9%). For nevi,
deeper cuts were asked in 5.3% of cases, comparedwith 5.1%
with the standard method. For melanomas, there was an in-
crease from 25.5% to 57.9%.
Turnaround Time
ThemedianTATsignificantlydecreasedduringthesecondtime
period from2days to 1 day for nevi, from5 to 2 days formela-
noma, and from 2 to 1 day for BCC (P < .001).
Discussion
The significant increase in positive section margins in non-
melanoma skin cancer lesions (from8.4% to 12.8%) indicates
a higher sensitivity of the EVD and DD method. In ISCC, the
visualization of a yellow-brownkeratotic or crusty surface on
EVDpermits delineationof the lesion and canguideus to sus-
picious margins. Many Bowenoid lesions show skip lesions.
Theymaybecoveredwithakeratotic crustor showbrowndots
corresponding to residual glomerular vessels.9 These charac-
teristics on EVD can disclose a positive margin and guide the
tissue sectioning. InBCCs,EVDwithDDproved to increase the
number of positivemargins significantly (from8.3% to 11.1%).
This was mainly due to superficial BCCs that may grow mul-
tifocal and may not be well delineated clinically.
As we described in a previous report,9 in some BCCs, the
loss of red and intensification of thewhite structureless areas
onEVD (reflecting a fibrosing stromal reaction) permits a bet-
termarginevaluation.6 Inothercasesof superficialBCCs, small
brown crusts or blue-gray ovoid nests (corresponding to pig-
mented basal nests) may give a hint to the most marginal tu-
moral nests. Nodular BCCs are mostly well delineated clini-
cally, and surgery often results in clean margins. Margin
positivity in these cases are mostly found in the deeper sec-
tion plane or deeper lateral sides, and this information can-
not be captured by EVD.
As demonstrated in a previous study,9 EVD of pigmented
lesions provides a sharp and detailed picture, allowing an ex-
cellent orientation and guided cutting of the lesions. Suspi-
cious superficial borders can easily be identified (Figure 2).
During both investigated periods, a similar percentage of
commonvariants of neviwas found. Only for Unna-type nevi
was a significant increase in the amount of nevi found (from
23% to 31.4%). This probably reflects more attention for sub-
typing and a lower threshold for diagnosing a nevus as papil-
lomatous since the use of EVD.
In 27.7% of nevi,many ofwhichwere removed because of
clinically atypical aspects, EVDwith DD led to a more specific
clinicopathologic subtyping (27.7% vs 10.3%without EVD and
Figure 2. Example of aMelanoma
MelanomaA
Original magnification × 12.5B
Original magnification × 50C
A, This superficial spreadingmelanomawith a thickness of 0.6mmon the
clavicula of awoman in her 60s shows on ex vivo dermoscopy a focal suspicious
margin (circle), confirmed to be positive after dotting and guided cutting. The line
indicates the section plane. B and C, Histopathologic images, hematoxylin-eosin.
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DD) (Table2).Theonlynevussubtype that couldbeeasily iden-
tifiedwithoutEVDandDDwerehypermelanotic flatand/or len-
tiginous nevi (8.4%vs 8.1% in 2015). Diagnoses of large nested
nevus increased from 1.2% to 2.2%. Ex vivo dermoscopy and
adapted cuttingmay have contributed to a better understand-
ingof thespecificarchitectureofmelanocytic lesions.Aftercor-
relationwithEVD,1.2%ofneviwerediagnosedasactivelygrow-
ingneviwithperipheralglobules,correspondingtoanotherspe-
Table 1. Positive Section Planes in Nonmelanoma Skin Cancer
Type of Tumor
General Hospital Period,
2008-2010, No./Total
No. (%)
Private Dermatopathology
Period, 2015,
No./Total No. (%) P Value
Nonmelanoma skin cancer 130/1540 (8.4) 239/1874 (12.8) <.001a
Squamous cell carcinoma 41/471 (8.7) 89/524 (16.9) <.001a
Bowen disease 12/129 (9.3) 37/194 (19.1) .02a
In situ NOS 1/10 (10.0) 3/9 (33.4) .21
Keratoacanthoma type SCC 3/48 (6.3) 5/41 (12.1) .33
Invasive SCC, other 25/284 (8.6) 44/280 (15.7) <.001a
Basal cell carcinoma 89/1069 (8.3) 150/1350 (11.1) .02a
Superficial 5/276 (1.8) 16/336 (4.8) .046a
Superficial/nodular 3/11 (27.3) 12/103 (11.7) .15
Nodular/noduloulcerative/nodulocystic 62/710 (8.7) 82/725 (11.3) .10
Nodular/infiltrative 2/8 (25.0) 2/13 (15.4) .59
Infiltrative/morpheiform 4/8 (50.0) 28/102 (27.5) .18
Basosquamous 4/21 (19.0) 1/6 (16.7) .89
Others or NOS 9/63 (14.3) 9/65 (13.8) .94
Abbreviations: NOS, not otherwise
specified; SCC, squamous cell
carcinoma.
a Statistically significant.
Table 2. Pigmented Lesions
Type of Nevus
General Hospital Period,
2008-2010, No. (%)
Private Dermatopathology Period,
2015, No. (%) P Value
Total biopsies 6526 8584
Nevi 1946 of 6526 (29.8) 2808 of 8584 (32.7) <.001a
Unna 449 (23.0) 884 (31.4) <.001a
Miescher 303 (15.6) 409 (14.6) .34
Flat 277 (14.2) 416 (14.8) .58
Blue 49 (2.5) 55 (2.0) .20
Spitz/Reed 74 (3.8) 91 (3.2) .30
Other 418 (21.5) 420 (15.0) <.001a
NOS 376 (19.3) 533 (19.0) .77
Clinicopathologic subtypes 200 (10.3) 777 (27.7) <.001a
Flat hyperpigmented/lentiginous 158 (8.1) 236 (8.4) .21
Large nested 23 (1.2) 63 (2.2) <.001a
Actively growing 0 35 (1.2) <.001a
Asymmetric shoulder 0 97 (3.4) <.001a
Fibrosing/sclerosing 6 (0.3) 168 (6.0) <.001a
Sclerosing 6 (0.3) 104 (3.7) <.001a
Superficial fibrosing 0 37 (1.3) <.001a
Perifollicular fibrosing 0 27 (1.0) <.001a
Nevus with dot 0 26 (0.9) <.001a
Irritative/traumatized 1 (0.1) 118 (4.2) <.001a
Eczematized 5 (0.3) 17 (0.6) .08
Recurrent 7 (0.4) 17 (0.6) .24
Nevi with moderate dysplasia 20 (1.0) 201 (7.2) <.001a
Nevi with severe dysplasia 11 (0.6) 40 (1.4) .008a
Melanoma in situ 42 (0.6) 59 (0.79) .74
Invasive melanomas 87 (1.3) 116 (1.4) .80
Ulceration in melanomas >1 mm 6 of 25 (24.0) 10 of 32 (31.3) .54
Nevi-associated melanomas 5 of 33 (15.2) 18 of 54 (33.3) .06a
Abbreviation: NOS, not otherwise
specified.
a Statistically significant.
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cific nevuswith large nests (Figure 3). This diagnosis is almost
impossible tomakewithout dermoscopic information.
Focal areas of fibrosis and/or sclerosis in nevi may cause
concern for the clinicianandoftenprompt resection, but these
areasmay be difficult to tracewithout EVD andDD. The diag-
nosisof a fibrosingor sclerosingnevusbyuseofEVDwasmade
in 6% of nevi compared with only in 0.3% without EVD. The
latter were all examples of fully sclerosing nevi. Many fibros-
ing, sclerosing nevi however, show only focal sclerosis, often
starting in a perifollicular way. Without EVD and DD these
areas can be missed. A correct interpretation of fibrosing/
sclerosing nevi is important because the differential diagno-
sis of these cases with regressive melanoma can be very dif-
ficult, even with the aid of EVD and DD information.
Nevi that were resected as consequence of the appear-
ance of a new black, blue, or brown dot were marked at this
dot and diagnosed readily through EVD without need for
deeper cuts or risk of transection of the dot.
Irritated, traumatizedneviwerealsosignificantlymore fre-
quently diagnosed than previously. There was also an in-
crease in thediagnosisof recurrent andeczematizednevi. This
increase, probably owing to the low number, was not signifi-
cant.Exvivodermoscopyoften revealed focal changes in these
lesions (crusts, erosions, pigment changes), permittingmark-
ing and guided cutting.
Ex vivo dermoscopy with DD resulted in a significant in-
crease ofmoderately and severely dysplastic nevi, from 1.0%
to 7.2% and from 0.6% to 1.4%, while the incidence of mela-
noma in situ, an invasivemelanoma, remained the same.This
observation suggests a higher sensitivity of EVDwithDD spe-
cifically for the identification of areas of significant dyspla-
sia. This is in linewith the retrospective study ofMerkel et al9
on theuseof dermoscopy-guidedhistologic sectioning for the
diagnosis of melanocytic lesions. This has clinical conse-
quences because in severely dysplastic nevi a broader resec-
tion to 0.5 cm is advised.
Besidesanadequatecontrolof sectionplanes,EVDwithDD
may also help to identify a preexisting nevus rest in melano-
mas or a focus of melanoma in a benign nevus. The observa-
tion of small areas with a residual regular network or con-
served globules in a dermoscopically malignant lesion can
disclose a preexisting nevus. Focal areas with a disturbed net-
work or a blue-gray aspect on EVD can guide the pathologist to
a small focus of melanoma in a benign nevus. By dotting and
therebyfacilitatingmicroscopic traceabilityof theseareas, there
was an increase in the diagnosis of residual nevi inmelanomas
Figure 3. Example of Actively Growing Nevus
NevusA Original magnification × 12.5B
Original magnification × 200C Original magnification × 200D
Top
Bottom
A, This pigmented lesion on the chest of a man in his 20s with a history of
growth in the past 6months shows a homogeneous center and a separated
peripheral rim of brown globules corresponding to a flat compound nevus. The
dotted blue-gray center (circle) corresponds to an area of chronic inflammation
andmelanophagia. The line indicates the section plane. B-D, Histopathologic
images, hematoxylin-eosin. C and D, The peripheral rim of globules corresponds
to larger or fused junctional nests.
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(from 15.2% to 33.3%). The diagnosis of ulceration in melano-
mas thicker than 1 mm increased from 24.0% to 31.3%. How-
ever, this increasewasnotsignificant,probablyowingtothe low
number of cases included in this study. The diagnostic poten-
tial of EVD and DD in identifying ulceration inmelanomas has
tobe furtherevaluated in larger series.Exvivodermoscopyand
DD can also help to identify themost suspicious areas for deep
invasion in melanomas. These areas often show a white-gray
colorassignofregressionorablue-grayaspectowingtothepres-
ence of deeper dermalmelanin pigment.
By using EVD andDD,we observedmore collision lesions
(0.07% to 1.07%). This increase may indicate a higher sensi-
tivityof thenewmethodcomparedwith the standardmethod.
Although most of these collision lesions are incidental find-
ings,without clinical or therapeutic consequences, in someof
thesecases, the identificationof a second lesioncanbeof clini-
cal importance (Figure 1).
Turnaround times decreased in the second period com-
paredwith the firstperiod: fornevi (from2days to 1day),mela-
nomas (from 5 days to 2 days), and BCC (from 2 days to 1 day)
significantly. In the private dermatopathology laboratory we
process tissues twiceadaycomparedwithonly 1overnight run
in the general pathology hospital laboratory, but this ex-
plains only in part the low TATs.
Deeper cutswere required in6.4%of cases comparedwith
5.3%before,which is anonsignificantdifference.Theneed for
deeper cuts is low compared with that reported in a previous
study (7.6% to 23.3%).10 With EVD-guided sectioning, most
deeper cuts are made to confirm or further examine focal le-
sions observed on the first cuts, whereas with the standard
method, cuts are often blind because of a discordance be-
tween the histological findings and the expected findings,
basedon theclinical informationormacroscopy.Theexact im-
pact on the accuracy and efficiency of working in an exclu-
sively dermatopathology environment comparedwith that in
a general pathology laboratory is difficult tomeasure. Never-
theless, we are convinced that EVD andDDmay contribute in
improving the accuracy and efficiency in dermatopathology.
Themain limitation of the study is that for the second period
the biopsies were processed in a new dermpat lab.
Conclusions
This retrospective evaluation shows that EVD with DD and
adaptedsectioningof skin tumors,permitsamoreaccuratehis-
tologicdiagnosis. It allowsbettermarginevaluation,betterun-
derstanding of lesional architecture, and specific evaluation
of remarkable/suspicious areas, either described by the clini-
cian or observed by the laboratory technician. Themethod is
easy to implement in adermatopathology setting. Inouropin-
ion,EVDwithDD is avaluablenewscientific tool tomakeclini-
copathologic correlations.Webelieve it is time for thepatholo-
gist involved intumoral skinevaluationandtheir technical staff
to learn dermoscopy and replace random transverse cutting
by lesion-specific and DD guided cutting.
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NOTABLENOTES
StanisławOstrowski, MD—TheOne State President AmongDermatologists in theWorld
MartynaWoltanowska, MD; Andrzej Wincewicz, MD, PhD, FEBP
Stanisław Ostrowski was born on October 29, 1892, in Lvov, Poland. He
studiedmedicine in Lvov—with partial education in Vienna, Austria—and
obtained his medical degree in 1919 in Lvov. When Poland struggled for
independence, his other mission was military service. He belonged to
Polishpatriotic organizations, suchas theRiflemen’sAssociation and the
Union of Active Struggle, and graduated from officer school and served
as a soldier andmedical physician in Joseph Pilsudski’s First Brigade and
Medical Chancellery of Legions duringWorldWar I. He defended Lvov in
1918 and in 1920 was the chief medical physician of the infantry regi-
ment. In 1920, he was honored with the medal Orlęta (“Eaglets”),
a commemorative order for the Lvov defenders against the Soviets.
Ostrowski was employed at the Department of Dermatology at
Warsaw University from 1922 to 1925. After he returned to Lvov, he
became the chief of dermatology ward of State General Public Hospi-
tal in Lvov, and in 1931 he became an associate professor.1,2 He investi-
gated the histology of unilateral epitheliomatous sebaceus nevus of
the head.3 He was a brilliant clinician who published his meticulous
observations about comparing 2 clinical appearances of tuberculids of
infant skin; attempted to cure different manifestations of tuberculosis
with a tuberculin cloth pad to enhance immunological response on
affected skin surfaces; published modifications of blood morphology
in rickets and comparative studies of the Mantoux tuberculin skin
test; examined light-sensitizing properties of acridine derivatives in
treatment of psoriasis and reported 20 years of experience with the
efficacy of novarsenobenzol in treating lues; studied vegetative ner-
vous reactions in tuberculosis and lues3; and described the dermato-
logical adverse effects of various contemporary medications (eg,
gold and arsenobenzole) as well as consequences of poisoning with
venoms.
In 1930, Ostrowski was elected to the Polish parliament, and in 1934
was appointed vice president of the city of Lvov. He was elected presi-
dentof this cityandheld thatoffice fromJune24, 1936, toSeptember23,
1939. After the Soviet invasion of Eastern Poland on September 17, 1939,
hewas imprisoned by the Soviets in Lvov and later transferred to Russia
(Lubianka, Butyrki,Moscow). As part of the amnesty agreement of 1941,
he left theworkcampinKrasnoyarsk,Siberia.DuringWorldWar II,hetook
part in battle campaigns in Italy with the army of General Wladyslaw
Anders. After the war, he supervised the dermatology department in
Penley, Wales, and later worked in the Military Hospital, Mossley Hill,
Liverpool, England, until his retirement in 1962. Hewas the president of
theRepublic ofPoland inexile fromApril 9, 1972, toApril 8, 1979.Hedied
in Charing Cross Hospital in London onNovember 22, 1982.1,2
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